Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma
Clinical trial NCT06061445 · UNKNOWN
Trial details
- NCT number
- NCT06061445
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-09
- Primary completion
- 2024-07-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.